Oscar Health downgraded by Piper Sandler with a new price target
$OSCR
Medical Specialities
Health Care
Piper Sandler downgraded Oscar Health from Overweight to Neutral and set a new price target of $14.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/14/2025 | $17.00 | Neutral | Goldman |
| 7/25/2025 | $14.00 | Outperform → Neutral | Robert W. Baird |
| 7/15/2025 | $11.00 | Neutral → Sell | UBS |
| 7/14/2025 | $14.00 | Overweight → Neutral | Piper Sandler |
| 7/11/2025 | $10.00 | Equal Weight → Underweight | Wells Fargo |
| 7/2/2025 | $17.00 | Underweight | Barclays |
| 6/24/2025 | Outperform → Mkt Perform | Raymond James | |
| 3/13/2025 | $20.00 → $16.00 | Overweight → Equal Weight | Wells Fargo |
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
8-K - Oscar Health, Inc. (0001568651) (Filer)
8-K - Oscar Health, Inc. (0001568651) (Filer)
8-K - Oscar Health, Inc. (0001568651) (Filer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Elektra Health ("Elektra"), a top virtual menopause care provider, and Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced a groundbreaking partnership offering the first-ever menopause health plan, HelloMeno, in the ACA marketplace. "Menopause is an inevitable transition for midlife women with disruptive symptoms and long-term health consequences, yet the healthcare system has long ignored it," said Jannine Versi, CEO & Co-Founder, Elektra. "Our partnership with Oscar ensures that millions of wom
Oscar Health, Inc. (NYSE:OSCR), a leading healthcare technology company, is introducing a suite of easy-to-use health plans and AI features for millions of people for 2026 open enrollment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020430145/en/The Oscar experience will be available in 573 counties in 20 states in 2026, including new expansions into Alabama and Mississippi. "Choice is power," said Mark Bertolini, CEO of Oscar Health. "Oscar's lineup of new products bring surprising new experiences and rewards to help members manage their health and get the most out of their plan. Everyone should be able to buy health cove
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following November 6, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform an
Goldman initiated coverage of Oscar Health with a rating of Neutral and set a new price target of $17.00
Robert W. Baird downgraded Oscar Health from Outperform to Neutral and set a new price target of $14.00
UBS downgraded Oscar Health from Neutral to Sell and set a new price target of $11.00
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G - Oscar Health, Inc. (0001568651) (Subject)
SC 13D/A - Oscar Health, Inc. (0001568651) (Subject)
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar's Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar's common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment. The awards were granted under Oscar's 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare. Kerry Sain has joined the company as the Executive Vice President of +Oscar, effective August 14, 2023, and Steven Kelmar will join as Executive Vice President and Chief of Staff to the CEO, effective September 21, 2023. In her role, Sain oversees the go-to-market strategy for the +Oscar business and will work closely with Mario Schlosser, President of Technology and Chief Technology Officer, to continue externa
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, today announced that Dr. Sean Martin, MD has been appointed to serve as the company's new Chief Medical Officer, effective immediately. Dr. Martin joined Oscar in 2016 and during his tenure has provided clinical leadership across a number of core clinical functions, including enterprise affordability, medical management, market performance, population health, and behavioral health. In his new role, he will be responsible for implementing Oscar's clinical capabilities and enhancing the quality of care and outcomes for its members. "Dr. Martin is an avid champion of the us
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following November 6, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform an
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the second quarter ended June 30, 2025, and reaffirmed its updated full year 2025 outlook across all metrics as provided in its preliminary financial results press release dated July 22, 2025. "We believe the individual market has long-term upside and is the future of healthcare," said Mark Bertolini, CEO of Oscar Health. "Oscar is well-positioned to manage through the market reset in 2025. We believe the market will stabilize next year, and expect to return to profitability in 2026. We are building the individual market into a healthcare marketplace for more consumers and businesses, and c
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data ("2Q Risk Adjustment Reports") from Wakely, an independent actuarial firm, that analyzes paid claims submissions through April 30, 2025 for most Marketplace insurance carriers. "The individual market is a competitive healthcare marketplace tha